The global troponin market is a lucrative space encompassing cardiac biomarkers that indicate heart muscle damage. Troponin, comprising Troponin I and Troponin T, are regulatory proteins that play a pivotal role in muscle contraction. They are released into the bloodstream upon myocardial infarction or heart attack, allowing clinicians to diagnose cardiac injury. Troponin assays possess high sensitivity and accuracy for detecting minimal amounts of troponin in the blood. Growing rates of cardiovascular diseases worldwide have augmented the demand for troponin tests in hospitals and diagnostic laboratories. Moreover, the rising geriatric population susceptible to heart ailments is a key factor stimulating the global troponin market. The Global Troponin Market is estimated to be valued at US$ 1.38 Bn in 2024 and is expected to exhibit a CAGR of 12.% over the forecast period 2024 To 2031.

Key Takeaways

Key players operating in the Global Troponin Market Size are Roche Diagnostics, Abbott Laboratories, Beckman Coulter, Response Biomedical, Vitro, Siemens Healthcare GmbH, Radiometer Medical ApS, bioMérieux SA, Thermo Fisher Scientific, Mitsubishi Chemical Europe, and other prominent players. Roche Diagnostics and Abbott Laboratories dominate the market with their wide troponin assay portfolios.

The growing demand for rapid and accurate cardiac biomarker testing is propelling the troponin market forward. Rising incidence of acute coronary syndrome and myocardial infarction cases have increased the clinical usage of troponin tests worldwide. Furthermore, advanced high-sensitivity troponin assays allow for early rule-out of AMI, improving patient management.

Geographically, the troponin market is expanding rapidly across emerging nations in Asia Pacific, Latin America, and Middle East regions. This is attributed to improving healthcare infrastructure, growing medical tourism, and increasing awareness regarding heart diseases. Manufacturers are focusing on emerging countries for sales and distribution networks to leverage new market opportunities.

Market Drivers

The growing geriatric population worldwide is a key factor driving the global troponin market. Age is a major risk factor for developing cardiovascular diseases. According to the WHO, worldwide life expectancy has increased from 64.2 years in 1990 to 72.6 years in 2019. Consequently, the population aged 65 years and above has surged significantly. As this demographic is more vulnerable to heart attacks and myocardial infarction, it has significantly contributed to the demand for troponin tests.
Get more insights on Global Troponin Market

Also read related article on Global Troponin Market